Know the risk you're actually taking.

Most portfolio apps show you what you own. JEGACAP shows what it means: how concentrated you really are, how much your holdings move together, and whether you're being paid for the risk. ASX and international shares, measured in Australian dollars.

Free to start. Pro is A$5 a month and Advanced A$9, cancel anytime. Log in

JEGA Portfolio HealthSimulated portfolio
49/ 100, fair
  • Diversification39
  • Concentration25
  • Risk-adjusted performance28
  • Volatility80
  • Correlation100
  • Downside resilience40
10 holdings worth $86,483 behave like 5.9 independent ones. CBA, BHP, MQG are 63% of the value, and the worst historical fall was 36%. Open the full demo

3,436 instruments on nine exchanges

  • ASXAustralia2,338
  • USUnited States527
  • TSEJapan218
  • LSEUnited Kingdom100
  • HKEXHong Kong63
  • TSXCanada60
  • NZXNew Zealand50
  • XETRAGermany40
  • EPAFrance40

See it in action

Real screens from the app, captured this week.

Universe and stats table filtered to the US, UK, German and Japanese markets, sorted by Sharpe ratio
Synthetic demo data

Every market you hold, in one table

Pick the exchanges you care about and compare return, volatility and Sharpe across all of them. International listings are converted to Australian dollars, so the figures include the currency moves you actually live with.

Included in every plan.

Statistics screen comparing BHP, CSL, Apple, Microsoft, Vodafone and Toyota: Sharpe, Sortino and beta per instrument
Synthetic demo data

Check whether two holdings really diversify each other

Choose up to 25 instruments, or use your own holdings, and get one- and three-year Sharpe and Sortino ratios, covariance and correlation matrices, and beta against the ASX 200.

Included in Pro and above.

Walk-forward backtest across the ASX and US markets: equity curve, annual return, volatility, drawdown and final weights
Synthetic demo data

Test a rule, not a portfolio picked with hindsight

The walk-forward backtest re-optimises on a rolling window and charges transaction costs at every rebalance, then tells you exactly how it narrowed the universe to get there.

Included in Pro and above.

Import panel with nabtrade selected, showing two buys imported and one sell row skipped

Bring your portfolio in from your broker

Upload a CommSec or nabtrade export, CSV or Excel. Buys arrive with their real trade dates, sells are recognised, and anything that can’t be matched is listed rather than silently dropped.

Included in every plan.

Getting started takes a few minutes

New accounts open on a short How to Use guide that walks through these in order.

Create a free account
  1. Add your holdings

    Type them in, or import a CommSec or nabtrade export.

  2. Read your Health Score

    One 0–100 score, broken into the six things that drive it.

  3. Go deeper where it’s weak

    Stress tests, statistics and Portfolio Lab, guided by the How to Use page.

What each plan includes

The free plan is the real product, not a trial. Pay only for the deeper tools.

FeatureFreeA$0ProA$5 / monthAdvancedA$9 / month
Holdings, plus CommSec and nabtrade import✓✓✓
JEGA Portfolio Health Score✓✓✓
Universe and per-instrument stats across nine markets✓✓✓
Statistics: covariance, correlation, CAPM beta–✓✓
Market and sector stress testing–✓✓
Walk-forward backtesting and the optimiser–✓✓
Portfolio Lab and correlation stress––✓
Leverage and LVR analysis––✓

Every number shows its working

The Health Score, shrinkage covariance, Sharpe and Sortino ratios, the optimiser and the backtester are each written out as an equation with a worked example. If a figure surprises you, you can check exactly how it was produced on the methodology page.

The whole platform is open source under the MIT licence, so you can read the code on GitHub that runs against your holdings. JEGACAP is early-stage and self-funded; the status page lists what's proven and what isn't yet. No sign-up needed for the free calculators.

Understand your portfolio before you take on more risk

JEGACAP provides quantitative portfolio analytics and educational decision-support tools. It is not a licensed investment fund, does not provide personal financial advice, and does not recommend individual securities. Past and backtested performance does not guarantee future results. Read the full disclaimer.